Top News

May 14, 2018
President Donald Trump announced his strategy for making prescription medicines more affordable and accessible in the United States.
May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
May 09, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.
May 07, 2018
Smaller review divisions will bring experts closer to decision processes and reduce bottlenecks, FDA leaders say.
May 01, 2018
By BioPharm International Editors
Fresenius Kabi claims that Akorn failed to fulfill several closing conditions.
Apr 19, 2018
By BioPharm International Editors
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Apr 19, 2018
By BioPharm International Editors
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.
Apr 12, 2018
By BioPharm International Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Apr 09, 2018
By BioPharm International Editors
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
Apr 06, 2018
By BioPharm International Editors
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
native1_300x100
lorem ipsum